Search

Your search keyword '"Helm, E"' showing total 21 results
Start Over Author "Helm, E" Publisher springer-verlag
21 results on '"Helm, E"'

13. Untersuchung von Bier, Würze und Hefe

Author

Rothenbach, E., Laster, R., Kolbach, P., Buse, R., Heinisch, O., Satava, D., Piratzky, W., Krwawnik, H., Heiduschka, A., Bischoff, Elisabeth, Windisch, W., Hamburg, M., Bode, G., Fink, H., Berwald, E., Staněk, V. I., Pavlas, P., Boas, Â., Herzfeld, A., Wieninger, F. M., and Helm, E.

Published
1935
Full Text
View/download PDF

19. [Therapeutic alternative or 2d choice drug. Trisodium phosphonoformate in cytomegalovirus retinitis].

Author

Gümbel H, Ohrloff C, Schalnus R, and Helm EB

Subjects
Drug Therapy, Combination, Fluorescein Angiography, Foscarnet, Humans, Infusions, Intravenous, Phosphonoacetic Acid administration & dosage, Acquired Immunodeficiency Syndrome drug therapy, Antiviral Agents administration & dosage, Chorioretinitis drug therapy, Cytomegalovirus Infections drug therapy, Ganciclovir administration & dosage, Opportunistic Infections drug therapy, Phosphonoacetic Acid analogs & derivatives
Abstract

From 01. 01. 1988 to June 1990, a total of 275 patients with AIDS had been examined in our ophthalmological out-patient clinic. The clinical diagnosis of a cytomegalovirus (CMV) retinitis was recorded in 56 of these patients (= 20.1%). The initial therapy, as usual, took the form of infusions of the virustatic drug ganciclovir at an induction dose of 10 mg/kg body weight per day (3 weeks), with a maintenance dose of 3.5-5 mg/kg body weight per day (5 days per week) thereafter. During maintenance therapy recurrences were observed in 15 cases and herpes simplex retinitis in 3, with progressive retinal destruction. Therefore we began treatment with trisodium phosphonoformate (Foscavir) at a dosage of 60 mg/kg body weight per day (3 weeks), continuing with maintenance therapy at 90 mg/kg body weight per day (7 days a week). After the induction dose 14 patients showed subjective improvement and satisfactory cicatrization of the retinal lesions. We monitored the retina by a standardized method and 50 wide-angle retinal photographs. One case of acute retinal necrosis (ARN) did not show any response to foscavir therapy. Typical side-effects of therapy with trisodium phosphonoformate were seldom seen: adverse events included renal dysfunction, neutropoenia, and asymptomatic hypocalcaemia. We conclude that trisodium phosphonoformate is an effective and well-tolerated agent for the treatment and prevention of relapse of CMW retinitis and can be used as an alternative ganciclovir.

Published
1991

20. Loss of hematopoietic progenitor cells CFU-GEMM, BFU-E, CFU-Mk, and CFU-GM in the acquired immunodeficiency syndrome (AIDS)?

Author

Ganser A, Carlo Stella C, Völkers B, Brodt KH, Helm EB, and Hoelzer D

Subjects
AIDS-Related Complex pathology, Colony-Forming Units Assay, Erythrocytes pathology, Granulocytes pathology, Humans, Megakaryocytes pathology, Monocytes pathology, Acquired Immunodeficiency Syndrome pathology, Hematopoietic Stem Cells pathology
Published
1987
Full Text
View/download PDF

21. [AIDS--a new threat].

Author

Helm EB and Stille W

Subjects
Acquired Immunodeficiency Syndrome transmission, Blood Transfusion, Deltaretrovirus isolation & purification, Female, Homosexuality, Humans, Infant, Newborn, Leukocyte Count, Male, Pregnancy, Pregnancy Complications, Infectious diagnosis, Retroviridae Infections transmission, Sarcoma, Kaposi diagnosis, Skin Neoplasms diagnosis, Acquired Immunodeficiency Syndrome diagnosis, Retroviridae Infections diagnosis
Published
1985

Catalog

Books, media, physical & digital resources
See catalog results